EMG
INSY

ETF Managers Group’s Insys Therapeutics, Inc. INSY Stock Holding History

ETF Managers Group’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,471,368
Closed -$5.08M – 593
2018
Q4 		$5.08M Buy
+1,471,368
New +$10.2M 0.24% 84
2018
Q3 		– Sell
-868,770
Closed -$75K – 635
2018
Q2 		$75K Buy
868,770
+218,872
+34% +$1.53M 0.01% 317
2018
Q1 		$3.87M Buy
649,898
+367,630
+130% +$3.04M 0.23% 82
2017
Q4 		$3.25M Buy
+282,268
New +$1.85M 0.24% 60

Other funds holding INSY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return

ETF Managers Group's INSY Position: Q1 2019 in Review

ETF Managers Group sold out of Insys Therapeutics, Inc. (INSY) in Q1 2019, closing a stake of 1,471,368 shares — an estimated $5.08M sold.

ETF Managers Group first reported a position in INSY in Q4 2017 and held it in 4 quarters. The position peaked at $5.08M in Q4 2018. 98 funds tracked by Wall St. Rank hold INSY as of Q1 2019.

  • ETF Managers Group reported no remaining Insys Therapeutics, Inc. position as of Q1 2019 after selling out during the quarter.
  • ETF Managers Group sold 1,471,368 Insys Therapeutics, Inc. shares in Q1 2019, an estimated $5.08M.
  • ETF Managers Group first reported a position in Insys Therapeutics, Inc. in Q4 2017 and held it in 4 quarters.
  • ETF Managers Group's Insys Therapeutics, Inc. position peaked at $5.08M in Q4 2018.
  • 98 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q1 2019.

Based on ETF Managers Group's 13F filing for Q1 2019, filed 7 May 2019.